Treatment Action Group

Index of articles from Treatment Action Group

About TAG

Founded in January, 1992, the Treatment Action Group, or TAG, is the first and only AIDS organization dedicated solely to advocating for larger and more efficient research efforts, both public and private, towards finding a cure for AIDS.

The Treatment Action Group (TAG) fights to find a cure for AIDS and to ensure that all people living with HIV receive the necessary treatment, care, and information they need to save their lives. TAG focuses on the AIDS research effort, both public and private, the drug development process, and health care delivery systems. We meet with researchers, pharmaceutical companies, and government officials to encourage exploration of understudied areas in AIDS research and speed up drug development, approval, and access. We work with the World Health Organization and community organizations globally, and strive to develop the scientific and political expertise needed to transform policy. TAG is committed to working for and with all communities affected by HIV.

Basic Science & Vaccines

TAG's work on basic science advocacy is devoted to speeding the conduct of research on the pathogenesis of HIV infection (how the AIDS virus causes disease) and the interactions between the virus and the immune system. We believe that a greater understanding in these areas will pave the way for better treatments for HIV infection and an eventual vaccine to protect against HIV transmission. TAG accomplishes its advocacy work by providing analyses of the scientific and practical impediments that slow the progress of basic research, offering recommendations to expedite progress and pushing for the adoption of these measures.

Vaccines and Immune Based Therapies

TAG also works to speed our progress towards the development of a vaccine against HIV transmission and immune based therapies for people with HIV. We work with industry and government sponsors of research in this area to push for more and better research, offering recommendations for change based on analyses of ongoing efforts.

Activism & Policy

TAG advocates for responsible public policy on AIDS research and treatment with our nation's leaders, including members of Congress and officials from the relevant agencies in the Executive Branch. We push for more funding for AIDS research and sensible legislative initiatives to foster better biomedical research. TAG also advocates for sound regulatory policy in the evaluation of AIDS drugs which balances the need for access to new agents and the need for reliable information about their clinical efficacy.

Antiretrovirals Project

TAG closely monitors HIV antiretroviral drugs in all stages of development, including post-marketing. We advocate for the expeditious development, proper clinical research and regulation, ease of access and optimal use of these drugs. We work with other treatment activists and researchers, FDA, NIH, and the pharmaceutical industry to achieve these objectives. TAG also helps educate members of the HIV community about antiretrovirals.

Hepatitis C Coinfection Project

TAG closely monitors new data on the epidemiology and natural history of HIV/HCV coinfection and HIV/TB coinfection, as well as the development of new diagnostics, prophylaxis and treatments for hepatitis C and tuberculosis, in both the pre- and postmarketing stages. We advocate for the expeditious development, proper clinical research and regulation, ease of access and optimal use of these drugs. We work with the pharmaceutical companies, NIH, FDA, researchers and other treatment activists to achieve these objectives. TAG also educates members of the HIV community about coinfection with hepatitis C and tuberculosis.

TB/HIV Project

The Project works to combat TB/HIV co-infection through a combination of community-based advocacy, education and mobilization efforts involving AIDS advocates in developed and developing countries. The TB/HIV Project is supported by a grant from the Bill & Melinda Gates Foundation.

TAGline

Would you like to receive TAGline at your home or office? A one-year subscription is $30 for individuals, $50 for institutions. (Subscription is automatic for anyone making annual donations to TAG at or above these amounts.) Click here to subscribe.

Contact

Treatment Action Group
611 Broadway, Ste. 608
New York, NY 10012-2608
Phone: (212) 253-7922
Fax: (212) 253-7923
E-mail: tagnyc@verizon.net